摘要:
Cosmetic or dermatological compositions contain an orchid extract obtained from at least a part of the species Vanda teres. These compositions and extracts are used as a cosmetic or dermatological agent for maintaining the structure of the skin, in particular by limiting the degradation of the extracellular matrix of the upper layers of the dermis and of the epidermis, and/or for reducing or delaying the effects of skin ageing, in particular the formation of wrinkles, and/or for obtaining a protective, corrective or restructuring effect on the skin, and/or as an anti-inflammatory agent. A method of cosmetic care for the skin is particularly intended for obtaining an effect of prevention or slowing down of the appearance of skin ageing signs.
摘要:
PROBLEM TO BE SOLVED: To provide a composition such as a cosmetic composition intended to lighten the skin coloring or to improve the uniformity of skin blood color, or to correct or attenuate skin spots or hyperpigmented skin areas. SOLUTION: An orchid extract obtained by extracting at least a part of Brassocattleya marcella Koss variety with a polar solvent or a mixture of polar solvents is used as a skin depigmentation agent. COPYRIGHT: (C)2010,JPO&INPIT
摘要:
Provided is a hair growth agent/hair tonic capable of improving the hair generation and growth effects and achieving the anti-canities effects. Specifically, the hair growth agent/hair tonic comprises, as an active ingredient, the extract obtained from the whole part of a plant belonging to the genus Cymbidium of the family Orchidaceae, and also has the anti-canities effect. Great Flower Marie Laurencin is particularly effective as the plant belonging to the genus Cymbidium of the family Orchidaceae. The amount of the extract to be added is 0.1 to 30% by weight, desirably 1.0 to 20% by weight, and particularly preferably 5.0 to 15% by weight.
摘要:
PROBLEM TO BE SOLVED: To identify a composition exhibiting excellent performances for enhancing drug bioavailability, particularly enhancing drug bioavailability by enhancing net drug absorption and/or reducing drug biotransformation in the intestinal wall by inhibiting cytochrome P450 drug metabolism and/or inhibiting P-glycoprotein (P-gp) drug transport. SOLUTION: One or more kinds of essential oils are concurrently administered with one or more kinds of oral pharmaceutical compounds (drugs) thereby to enhance bioavailability of the drug. COPYRIGHT: (C)2009,JPO&INPIT